Effects of race on Lipid-Lowering management in hospitalized patients with coronary heart disease

American Journal of Cardiology

Volumn 93, Issue 9, 2004, Pages 1167-1170

  Dressler, Daniel D ^b   Jacobson, Terry A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; ASSOCIATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; EVALUATION; FEMALE; HEALTH PROGRAM; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; COMORBIDITY; CONTINENTAL POPULATION GROUPS; CORONARY DISEASE; FEMALE; GEORGIA; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICS; TREATMENT OUTCOME;

EID: 1942436119     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.01.052     Document Type: Article

References (7)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 269:1993;3015-3023.
2. Lacy C.R., Suh D.-C., Barone J.A., Bueno M., Moylan D., Swartz C., Kudipudi R.V., Kostis J.B. Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting. Arch Intern Med. 162:2002;468-473.
3. Fonarow G.C., Gawlinski A., Moughrabi S., Tillisch J.H. Improved treatment of coronary heart disease by implementation of a cardiac hospitalization atherosclerosis management program (CHAMP). Am J Cardiol. 87:2001;819-822.
4. Stenestrand U., Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 285:2001;430-436.
5. Serruys P.W.J.C., Feyter P.D., Macaya C., Kokott N., Puel J., Vrolix M., Branzi A., Bertolami M.C., Jackson G., Strauss B., et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention a randomized controlled trial. JAMA. 287:2002;3215-3222.
6. Muhlestein J.B., Horne B.D., Bair T.L., Li Q., Madsen T.E., Pearson R., Anderson J.L. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol. 87:2001;257-261.
7. American Heart Association. Get with the guidelines. Available at: http://www.americanheart.org/presenter.jhtml?identifier=1165 Accessed January 15, 2004.